Drawing for GENTLEBEAM

USPTO serial 98859301

GENTLEBEAM

Reviewed by CopyMark Law Group

Status 730Notice of Allowance
Filing date
Status date
Registration date
—
Examiner
FITZSIMONS, MICHAEL R
Law office
INTENT TO USE SECTION

What this means

The USPTO has issued a Notice of Allowance. To complete registration you generally need to file a Statement of Use or an extension request before the deadline.

Status 730: Status 730 means you filed the first six-month extension to delay filing a Statement of Use after a Notice of Allowance. You must file a Statement of Use or another extension before the new deadline.

Need help with GENTLEBEAM?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Notice of Allowance, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $947*

Plus Government fees of $450

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Christina L. Martini

Christina L. Martini Dechert LLP444 West Lake Street, Suite 2100Chicago, IL 60606United States

Goods and services

ClassDescriptionStatusFirst use
009Downloadable computer software for distributing, analyzing, and viewing pathology image results generated from machine learning and artificial intelligence algorithms, in the field of pathology and treatment planning for surgical and non-surgical interventions of nonmelanoma skin cancer as well as other skin conditions; computer network server hardware for cloud-based image management software for distributing, analyzing, and viewing pathology image results generated from machine learning and artificial intelligence algorithms, in the field of pathology and treatment planning for surgical and non-surgical interventions of nonmelanoma skin cancer as well as other skin conditions; downloadable computer software platform for distributing, analyzing, and viewing pathology image results generated from machine learning and artificial intelligence algorithms, in the field of pathology and treatment planning for surgical and non-surgical interventions of nonmelanoma skin cancer as well as other skin conditions; downloadable computer software for communication between computers over a local network for patient and clinical tracking for distributing, analyzing, and viewing pathology image results generated from machine learning and artificial intelligence algorithms, in the field of pathology and treatment planning for surgical and non-surgical interventions of nonmelanoma skin cancer as well as other skin conditions; downloadable computer application software for cloud computing services for distributing, analyzing, and viewing pathology image results generated from machine learning and artificial intelligence algorithms, in the field of pathology and treatment planning for surgical and non-surgical interventions of nonmelanoma skin cancer as well as other skin conditions; downloadable cloud computing software for distributing, analyzing, and viewing pathology image results generated from machine learning and artificial intelligence algorithms, in the field of pathology and treatment planning for surgical and non-surgical interventions of nonmelanoma skin cancer as well as other skin conditionsACTIVE—
010Medical devices used in the treatment of skin cancer, keloids, and other cutaneous and subcutaneous lesions, diseases, and other cancers; Radiotherapy apparatus; X-ray diagnostic apparatus; Robotically-guided X-ray quality control and beam quantification apparatus for medical use; Treatment Planning Systems (TPS) comprising computer hardware and medical imaging apparatus, and featuring embedded computer software with computer vision, diagnostic imaging guidance, pattern recognition, and decision support with integrated safety for treatment accuracy and patient safety optimization; Hybrid medical imaging apparatus comprised of a plurality of any combination of confocal microscopy, photo-acoustics, high-frequency ultrasound, LiDAR, and optical imaging modalities for radiotherapy image-guidance and diagnostics; X-ray apparatus for medical purposes; medical therapy instruments, namely, medical radiotherapy instruments; image-guided, robotically-assisted, intensity modulated vector beam pixelated conformal mobile X-ray therapy device used in the treatment of skin cancers, keloids and dermatological skin lesions; medical equipment and devices, namely, radiation therapy apparatus; medical radiation apparatus, namely medical radiotherapy instrumentsACTIVE—
042Scientific research and development in the field of pathology using artificial intelligence (AI), machine vision, and machine learning algorithms to analyze images for medical and scientific research diagnostic purposes for use by consultants, clinicians, patients, and caregivers in healthcare; application services provider (ASP) featuring computer artificial intelligence software for image analysis for use in the healthcare field, namely, software for accessing and viewing patient pathology images and information for use by consultants, clinicians, patients, and caregivers in healthcare; Providing on-line non-downloadable artificial intelligence software for image analysis for use in the healthcare field, namely, for accessing and viewing patient pathology image information for use by consultants, clinicians, patients, and caregivers in healthcare; Providing online non-downloadable software for utilizing mobile and distributed computing data and application functionality access and meshing; Providing online non-downloadable software for patient-centric geo-location-based workflow and data distribution and management; Providing online non-downloadable cloud computing software for accessing and viewing patient pathology images and information for use by consultants, clinicians, patients, and caregivers in healthcare; Providing virtual computer systems and virtual computer environments through cloud computing in the field of healthcare; Providing temporary use of online non-downloadable cloud computing software using artificial intelligence for accessing and viewing patient pathology images and information for use by consultants, clinicians, patients, and caregivers in healthcare; Providing temporary use of online non-downloadable computer software for communication between computers over a local network; Providing temporary use of on-line non-downloadable computer application software for cloud computing services for distributing, analyzing, and viewing pathology image results generated from machine learning and artificial intelligence algorithms, in the field of pathology; Providing online non-downloadable cloud computing software for distributing, analyzing, and viewing pathology image results generated from machine learning and artificial intelligence algorithms, in the field of pathologyACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Apr 22, 2026EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Apr 21, 2026EX1GSOU EXTENSION 1 GRANTED—
Apr 21, 2026EXT1SOU EXTENSION 1 FILED—
Apr 21, 2026EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Mar 18, 2026TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Mar 18, 2026ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 18, 2026REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Mar 3, 2026NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Jan 6, 2026NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jan 6, 2026PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Dec 31, 2025NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Dec 9, 2025CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Nov 21, 2025TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Nov 21, 2025CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Nov 21, 2025TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Aug 12, 2025TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Aug 12, 2025ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Aug 12, 2025REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Aug 12, 2025XELGAPPLICATION EXTENSION GRANTED/RECEIPT PROVIDED—
Aug 12, 2025XELRAPPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED—
May 24, 2025GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 24, 2025GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 24, 2025CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 19, 2025DOCKASSIGNED TO EXAMINER—
May 19, 2025NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Nov 18, 2024NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance